Phase I dose escalation study of telatinib (BAY 57-9352) in patients with advanced solid tumours.
Strumberg D, Schultheis B, Adamietz IA, Christensen O, Buechert M, Kraetzschmar J, Rajagopalan P, Ludwig M, Frost A, Steinbild S, Scheulen ME, Mross K.
Strumberg D, et al. Among authors: steinbild s.
Br J Cancer. 2008 Nov 18;99(10):1579-85. doi: 10.1038/sj.bjc.6604724.
Br J Cancer. 2008.
PMID: 19002179
Free PMC article.
Clinical Trial.